Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab

NCT07041268 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: rituximab

Sponsor

Pirogov Russian National Research Medical University